JONATHAN GILLIS
CIK 1709954 · CAAO and PAO · last filed 2026-04-29
JONATHAN GILLIS is a CAAO and PAO who has filed 8 SEC Form 4 insider transactions across 3 companies since 2017. The most recent filing shows the insider sold $2.1M of MPLT on Apr 29, 2026. Across all open-market trades the lifetime net is −$2.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$5.93M
3
8
-$2.18M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MPLT | CAAO and PAO | 213,517 | $27.75 | $5.93M | -$2.18M | 5 | 2026-04-29 |
| Tempest Therapeutics, Inc. (MLND) Delisted | Senior Vice President, Finance | — | $15.90 | — | $0 | 1 | 2018-12-11 |
| Tempest Therapeutics, Inc. (OVAS) Delisted | Senior Vice President, Finance | — | — | — | $0 | 2 | 2018-02-09 |
Recent Filings
8 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-29 | MPLT | Sell (S) | −69,835 | -$2.09M | EDGAR |
| 2026-04-17 | MPLT | Sell (S) | −3,590 | -$95.5K | EDGAR |
| 2026-02-09 | MPLT | Grant (A) | +6,020 | $0 | EDGAR |
| 2026-01-29 | MPLT | Tax (F) | −22,050 | -$396.5K | EDGAR |
| 2025-10-28 | MPLT | Grant (A) | +30,565 | $0 | EDGAR |
| 2018-12-11 | Tempest Therapeutics, Inc. (MLND) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-02-09 | Tempest Therapeutics, Inc. (OVAS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-06-23 | Tempest Therapeutics, Inc. (OVAS) Delisted | Grant (A) | — | $0 | EDGAR |